AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine
Insider Brief Recursion and Exscientia announced their business combination has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion. Recursion unveils post-combination technology-enabled